Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting today.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Baxter International
Symbol: BAX
Recent BAX Stock Price: $57.17
Average Analyst Price Target: $70.73 (23.72%)
BAX Market Cap: $28.79B
Expected Ex-Dividend Date for BAX stock: Sep 01 2022
Expected Payment Date for BAX stock: Oct 03 2022
Expected Dividend & Yield for BAX stock: 1.98%
Recent Analyst Action: Amit Hazan, analyst at Goldman Sachs, reiterates coverage on Baxter International (BAX) stock in the Healthcare sector with a Sell rating and a price target of $ 60 (3 weeks ago).
TipRanks.com also reports that Baxter International stock currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $70.73 . The target pricing ranges from a high forecast of $87.00 down to a low forecast of $60.00. Baxter International (BAX)’s last closing stock price was $57.17 which would put the average price target at 23.72% upside.Here are 3rd party ratings for BAX stock:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Bottom 35% (163 out of 252)
--------------------------------------------------------------------------
Perrigo Company
Symbol: PRGO
Recent PRGO Stock Price: $39.16
Average Analyst Price Target: $50.00 (27.68%)
PRGO Market Cap: $5.27B
Expected Ex-Dividend Date for PRGO stock: Sep 01 2022
Expected Payment Date for PRGO stock: Sep 20 2022
Expected Dividend & Yield for PRGO stock: 2.55%
Recent Analyst Action: Stephanie Wissink, analyst at Jefferies, reiterates coverage on Perrigo Company (PRGO) stock in the Healthcare sector with a Buy rating and a price target of $ 50 (2 months ago).
TipRanks.com also reports that Perrigo Company stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $50.00 . The target pricing ranges from a high forecast of $50.00 down to a low forecast of $50.00. Perrigo Company (PRGO)’s last closing stock price was $39.16 which would put the average price target at 27.68% upside.Here are 3rd party ratings for PRGO stock:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Sell, Bottom 35% (163 out of 252)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
